Ruti Aga and the Clinic That Never Existed: The Real Arithmetic Behind a Six-Year Ban

The clinic named on the prescription Ruti Aga submitted as her defence has stated plainly that it has nothing to do with that prescription. The heaviest sentence in the Athletics Integrity Unit (AIU) statement was not about a banned substance at all. It was that the "doctor" who wrote the prescription was a member of Aga's own family, held no medical registration, and claimed to have used an "old prescription pad from a former workplace". Three independent verifications — the document, the institution named on it, and the registration of the person who signed it. All three failed. That night I added another name to the ledger in which I count not the winners but the disappearances, the one nobody has ever commissioned.

Aga is an Ethiopian marathon runner, 32 at the time of the statement. She won the 2026 Tokyo Marathon and finished second at three World Marathon Majors. The personal-best figure recorded in my old notes I am still verifying independently, so I will not present it as fact; what is verified is that a Tokyo title and three Major runner-up finishes belong to an athlete who sat inside the brutal 2:20-and-change benchmark. That standard is high in Ethiopian women's marathoning, and the national depth is so extreme that even an athlete of that class is not automatically selectable.

In March she won a half marathon in China. In what time is stated nowhere. The AIU statement offers no mark, no split, no field strength, so I will make no claim about the quality of that race. What matters is that a road race's testing window opens at 23:59 the day before the race, which means an injection given days earlier can still surface in an in-competition sample. The entire case sits inside that window.

Here the media reporting contains a technical error that makes the case illegible unless it is corrected. Methylprednisolone was described as a "prohibited steroid" and as classed performance-enhancing by WADA. That is incompatible with the List. Methylprednisolone is a glucocorticoid, WADA Prohibited List class S9 — not an anabolic steroid, which is S1. And S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes.

The consequence is that the whole technical spine of this case is about route and timing, not about steroids. A knee injection given out-of-competition is entirely legal medicine. The problem arises when residues remain in a sample taken on competition day. An athlete with genuine medical records, a therapeutic use exemption and a correct washout interval had a defence available — the case might never have been brought, or would have been far lighter. Aga closed that road herself by producing a forged document.

The ban is six years and the arithmetic is plain: two years for the presence of a prohibited substance, four years for tampering — the misleading interview answers and the forged document. Two plus four is six. That is the standard sanction under the 2026 WADA Code, not an exceptional ruling. The ban runs from 10 September, the same date her provisional suspension began; backdating sounds like a concession but is only bookkeeping, not relief.

She is 32. The ban expires when she is about 38. The 2028 Olympic cycle is gone entirely, and for a 38-year-old with a doping record, selection in Ethiopia's women's marathon is close to impossible. On paper this is a six-year ban; in effect it is the end of a career.

Now the ledger nobody keeps. The result and prize money from that March race: void. Ranking points accrued after that date: void. And one more name off the start list — a name that will not appear in any results table, because it finished first, not fourth. Fabrication cases tend to run in this order: first the door to the podium closes, then a page is torn out of the record book.

The statement cites a knee injury. Chronic knee pathology is a well-known load-bearing failure in marathoners, and treatment often takes exactly this form of injection. The real danger is that the root cause is structural rather than individual: an injured runner faces pressure to keep racing because her income runs on appearance fees, and the cheapest, most available pain-masking tool is this glucocorticoid. The forged prescription is a product of untreated medical governance, not a separate event.

I have spent years reading label-race start lists, entry sheets and results against one another, and they are what tell me what kind of support stands behind a name. Sitting on the results desk in Manchester, the first lesson I learned was that accuracy is a form of care. More than twenty years on, the habit of that results crew has not let go: for an athlete whose career is decided by a hundredth of a second, writing approximate numbers is not sloppiness, it is a kind of dishonesty. So I will not write what I do not know — not the March time, not her personal best. And I will insist that before anyone pronounces a six-year ban over a drug, they establish which class that drug belongs to, because much of the reporting got that wrong.

The first reflex is to say: six years for a drug with no proven endurance benefit? But put the number first — 2+4 is the standard Code sanction, and the heavy half comes not from a banned substance but from a forged piece of paper. The real story is the document, not the drug. The second, less intuitive point: the strongest signal from this case is that the enforcement frontier has shifted from detection to document verification. In several East African road-racing cases the first violation involves a substance and the second, heavier one involves a manufactured explanation. The greatest risk is no longer doping; it is the defence narrative. The third point, left conveniently unmentioned: only the family member is named. Whether the agent, management or training camp was investigated is not stated. Whether an athlete fabricates a prescription alone or is advised to do so has been left open. And for fairness, the reverse test also applies: could the knee injury be real? Yes. Could the injection be legitimate treatment? Yes. That plausibility is exactly why the forgery becomes the decisive fact — real treatment is proved by real records, not by a manufactured pad.

The map ahead is clear. China's label-race circuit has been the lucrative layer between Majors for East African marathoners — appearance-fee money with a light racing load. That same layer is now the AIU's highest-yield testing zone; the earnings market and the testing market have collided on the same track. The informal medical networks serving one training cluster supply the same prescriptions to everyone, and there are more names in the pipeline. What remains outstanding in this case is the return of prize money, the cancellation of points, and possibly a national-level criminal referral for document forgery — outside AIU jurisdiction, and therefore absent from any statement. I did not write in my ledger who won this week. I wrote that equity begins where the camera stops and someone still writes the name down. Ruti Aga's name will no longer appear on any start list after 10 September. Who will keep counting the one that does not?